{"identifier":"/us/usc/t21/s2004","title_num":"21","num":"§ 2004.","heading":"Information sharing","status":null,"guid":"id5a08a2ae-80c6-11ef-b1ed-eb23b1841a39","source_credit":"(Pub. L. 117–103, div. Q, title III, § 305, Mar. 15, 2022, 136 Stat. 817.)","seq_in_title":699,"parent_identifier":"/us/usc/t21/ch25/schI","ancestors":[{"identifier":"/us/usc/t21","level":"title","num":"Title 21—","heading":"FOOD AND DRUGS","status":null,"is_section":false},{"identifier":"/us/usc/t21/ch25","level":"chapter","num":"CHAPTER 25—","heading":"MISCELLANEOUS ANTI-DRUG ABUSE PROVISIONS","status":null,"is_section":false},{"identifier":"/us/usc/t21/ch25/schI","level":"subchapter","num":"SUBCHAPTER I—","heading":"ANTI-DOPING AGENCY","status":null,"is_section":false}],"xml":"<section xmlns=\"http://xml.house.gov/schemas/uslm/1.0\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\" xmlns:dc=\"http://purl.org/dc/elements/1.1/\" xmlns:dcterms=\"http://purl.org/dc/terms/\" style=\"-uslm-lc:I80\" id=\"idf53242ca-6371-11ee-b61f-b0ed6a65d7e9\" identifier=\"/us/usc/t21/s2004\"><num value=\"2004\">§ 2004.</num><heading> Information sharing</heading><content>\n<p style=\"-uslm-lc:I11\" class=\"indent0\">Except as otherwise prohibited by law and except in cases in which the integrity of a criminal investigation would be affected, pursuant to the obligation of the United States under Article 7 of the United Nations Educational, Scientific, and Cultural Organization International Convention Against Doping in Sport done at Paris <date date=\"2005-10-19\">October 19, 2005</date>, and ratified by the United States in 2008, the Attorney General, the Secretary of Homeland Security, and the Commissioner of Food and Drugs shall provide to the United States Anti-Doping Agency any relevant information relating to the prevention of the use of performance-enhancing drugs or the prohibition of performance-enhancing methods.</p>\n</content><sourceCredit id=\"idf53242cb-6371-11ee-b61f-b0ed6a65d7e9\">(<ref href=\"/us/pl/117/103/dQ/tIII/s305\">Pub. L. 117–103, div. Q, title III, § 305</ref>, <date date=\"2022-03-15\">Mar. 15, 2022</date>, <ref href=\"/us/stat/136/817\">136 Stat. 817</ref>.)</sourceCredit>\n<notes type=\"uscNote\" id=\"idf53242cc-6371-11ee-b61f-b0ed6a65d7e9\">\n<note style=\"-uslm-lc:I74\" role=\"crossHeading\" topic=\"editorialNotes\" id=\"idf53242cd-6371-11ee-b61f-b0ed6a65d7e9\"><heading class=\"centered\"><b>Editorial Notes</b></heading></note>\n<note style=\"-uslm-lc:I76\" topic=\"codification\" id=\"idf53242ce-6371-11ee-b61f-b0ed6a65d7e9\"><heading class=\"centered smallCaps\">Codification</heading>\n<p style=\"-uslm-lc:I21\" class=\"indent0\">Section was enacted as part of the United States Anti-Doping Agency Reauthorization Act of 2022 and also as part of the Consolidated Appropriations Act, 2022, and not as part of title VII of <ref href=\"/us/pl/109/469\">Pub. L. 109–469</ref> which comprises this chapter.</p>\n</note>\n</notes>\n</section>","provision":null,"duplicates":[],"release":{"label":"118-90","currency_date":"2024-09-30","congress":118,"law_num":90,"excluded_laws":[],"update_num":null,"seq":336,"is_partial":false,"caveat":null,"titles_affected":["01","02","06","07","16","18","21","22","31","38","42","47","48","49"],"ingested_titles":[]},"served_from":{"label":"118-90","currency_date":"2024-09-30","congress":118,"law_num":90,"excluded_laws":[],"update_num":null,"seq":336,"is_partial":false,"caveat":null,"titles_affected":["01","02","06","07","16","18","21","22","31","38","42","47","48","49"],"ingested_titles":[]},"content_first_seen":{"label":"118-16","currency_date":"2023-10-02","congress":118,"law_num":16,"excluded_laws":[],"update_num":null,"seq":310,"is_partial":false,"caveat":null,"titles_affected":["06","18","21","25","26","42","48","49","51"],"ingested_titles":[]},"is_exact":true,"note":null}